BAJAJ FINSERV DIRECT LIMITED
Latest IPO Information

Sudeep Pharma Ltd. IPO

IPO Date: Nov 21 to Nov 25 2025

Listing Date: Nov 28 2025

Objective

(i)Capital expenditure towards procurement of machinery for our production line located at Nandesari Facility I; and(ii)General corporate purposes.

IPO Details

Face Value ₹ 1.00 Per Share
Issue Size ₹ 594.81 - 626.50 Cr
Price Band ₹ 563.00 - ₹ 593.00 Per Share
Market LOT 25 shares
Issue Type Book building

About Company

We are a technology led manufacturer of excipients and specialty ingredients for the pharmaceutical, food and nutrition industries and are dedicated to contributing to the global healthcare ecosystem. We leverage our inhouse developed technologies for processes such as encapsulation, spray drying, granulation, trituration, liposomal preparations and blending in an effort to drive innovation in our operations. We have established a presence in both, domestic and international markets, including key regions such as the United States, South America, Europe, the Middle East, Africa, and Asia-Pacif .... ic.We are one of the largest producers of food-grade iron phosphate for infant nutrition, clinical nutrition, and the food and beverage sectors, in terms of production capacity with a combined annual manufacturing capacity of 65,579 metric tons (“MT”), as of December 31, 2024. (Source: F&S Report) As of the same date, one of our Manufacturing Facilities has been approved by the United States Food and Drug Administration (“USFDA”) for the manufacture of mineral-based ingredients. We are one of the largest exporters of mineral ingredients for pharmaceutical, food and nutrition industries from India to global markets in terms of volume of products exported during 2024 as of December 31, 2024. (Source: F&S Report) We were the only company in India and one of nine companies globally with certification of suitability issued by the Council of Europe (“CEP”) and written confirmation certification for sale of calcium carbonate as an active pharmaceutical ingredient (“API”) in the European Union as of December 31, 2024. (Source: F&S Report) We are one of the pioneers in India to introduce a product range of liposomal ingredients for nutrient absorption and stability. Read More
Address

-

City

-

State

-

Pincode

-

Phone

-

Email

-

Website

-

About IPO

Listed At NSE/BSE
Lead Manager IIFL Capital Services Ltd.
Promoters
Shanil Sujit Bhayani
Sujit Jaysukh Bhayani
Riva Resources Pvt Ltd.
Bhayani Family Trust
Sujeet Jaysukh Bhayani HUF
Avani Sujit Bhayani

Promoter's Holding

Registrar

MUFG Intime India Pvt Ltd.

+91 810 811 8484
rnt.helpdesk@in.mpms.mufg.com
https://in.mpms.mufg.com/

Latest News

Apr
10
2026
EQUITY Posted on Apr 10th 2026

Sudeep Pharma informs about certificate

Sudeep Pharma has informed that it enclosed certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, issued by the Company’s Registrar and Share Transfer Agent, MUFG Intime India for the quarter ended on 31st March 2026.
The above information is a part of company’s filings submitted to BSE.  
Read More
Mar
17
2026
EQUITY Posted on Mar 17th 2026

Sudeep Pharma informs about analyst meet

Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, Sudeep Pharma has informed that the officials of the Company will be meeting Investors/Analysts (Participants) on 23rd March 2026 at 12:00 pm onwards in Mumbai (1x1 / Group). Discussions will be based on publicly available information. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.

Read More
Feb
12
2026
EQUITY Posted on Feb 12th 2026

Sudeep Pharma informs about earnings call transcript

Sudeep Pharma has informed that it enclosed Earnings Call Transcript for the earnings call held on 9th February 2026 to discuss the operational and financial performance of the Company for the third quarter and nine months ended on 31st December 2025.
The above information is a part of company’s filings submitted to BSE.
Read More
May
7
2026
EQUITY Posted on May 7th 2026

Dachepalli Publishers informs about outcome of board meeting

Pursuant to Regulation 30 read with Para A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Dachepalli Publishers has informed that the meeting of the Board of Directors (the Board) of the Company held today, 7th May, 2026, commenced at 12:00 noon and concluded at 04:00 PM considered and approved the Audited Financial Statements and its Independent Auditor Report for the period ended March 31, 2026. The said Audited Financial Results were reviewed by the Audit Committee and thereafter approved by the Board. In this regard, it has enclosed copies of the following: i. Statement showing the Audited Financial Statements including Statement of Assets and Liabilities, Profit and Loss Statement and Cash Flow Statement for the period ended March 31, 2026. ii. Independent Auditor Report on the financial statements of the Company issued by the Statutory Auditors pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The above information is a part of company’s filings submitted to BSE.
Read More
May
7
2026
EQUITY Posted on May 7th 2026

Shree Ram Twistex submits board meeting intimation

Shree Ram Twistex has informed that pursuant to Regulation 29(1)(a) of the SEBI (LODR) Regulations, 2015, the Board of Directors Meeting of Shree Ram Twistex is scheduled to be held on Wednesday, May 13th, 2026, at the registered office of the Company inter alia, to: 1) To consider and approve Audited Financial Results for year ended March 31, 2026 along with Independent Audit Report of the Company; 2) To consider and approve the appointment of Internal Auditor of the Company for the financial year 2026- 27; 3) To consider and approve the appointment of Cost Auditor of the Company for the financial year 2026-27; 4) To consider and approve the Draft Monitoring Agency Report and Comments of the Members of the Board of Directors, if any, thereon; and 5) To Consider and discuss any other items as may be decided by the Board of Directors of the Company.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Frequently Asked Questions

What is the issue size of Sudeep Pharma Ltd. IPO?

The issue size of Sudeep Pharma Ltd. IPO is ₹594.81 - 626.50 crore.

The Sudeep Pharma Ltd. IPO opens for subscription on 2025-11-21 and closes on 2025-11-25.

The price range of Sudeep Pharma Ltd. IPO is ₹563.00 to ₹593.00.

The lot size of Sudeep Pharma Ltd. IPO is 25 shares.

The registrar of Sudeep Pharma Ltd. IPO is MUFG Intime India Pvt Ltd..

Sudeep Pharma Ltd. IPO will be listed on NSE/BSE .

You will typically receive a confirmation message or notification from your broker or trading platform shortly after placing your IPO order. This confirms that your application has been submitted successfully. You can also check the order status in the IPO section of your trading account or app.

Apply early with valid UPI and PAN before 2025-11-25 to increase your chances.

The listing date of Sudeep Pharma Ltd. IPO is 2025-11-28.

An Initial Public Offering (IPO) is when a private company sells shares to the public for the first time, enabling investors to purchase these shares and gain partial ownership in the business. For instance, if a well-known tech firm wants to grow and requires additional funds, it might choose to go public through an IPO. During this process, investors can buy shares, and the company’s stock starts trading on the stock exchange on the day of the IPO listing.

Investors can apply for an IPO through their bank or brokerage account. Many trading platforms have a specific section for IPOs where users can submit their applications online.

The primary market is where shares are offered to the public for the first time via an IPO. After the IPO, shares are traded on the secondary market (stock exchange), where existing shareholders can sell to new buyers.

Investing in an IPO offers the opportunity to become an early investor in companies with high growth potential, at a price which may be lower than their post-listing market value. It provides a chance to participate in the company's growth journey from its early stages. However, IPO investments also come with inherent risks, such as market volatility and uncertainties about the company's future performance.

The price of an IPO is established through a systematic process known as "book building." In this method, investors bid within a given price range, and the final price is set based on demand and market conditions. Several factors play a crucial role in determining the IPO price, including:

Past Financial Performance: Evaluating the company's revenue, profits, and financial stability over time

Growth Potential: Assessing future prospects based on the company's business model and market opportunities

Industry Peers: Comparing valuation metrics with similar companies in the same sector

Larger Industry Picture: Analysing overall industry trends and economic conditions that could impact the company's performance

The lock-in period for IPO shares refers to a duration during which specific investors are restricted from selling their shares post-listing. This period varies based on the type of investor:

Promoters: The lock-in period for promoters ranges from 6 months to 18 months, ensuring their commitment to the company's long-term growth

Anchor Investors: Typically, anchor investors face a shorter lock-in period of 30 to 90 days, depending on regulatory norms and the specific IPO

IPOs can be volatile and may not perform as expected in the short term. Investors risk losing capital if the stock price drops after listing, especially if the company does not meet its growth projections.

Information on upcoming IPOs is often available through brokerage platforms, financial news sites, and regulatory bodies like SEBI, which publishes details on companies going public. You can also get these details under the upcoming IPO section on Bajaj Markets.

Eligibility for an IPO typically includes:

Retail Investors: Individuals who invest in smaller amounts, usually under the “retail investor” category, with certain limits

Qualified Institutional Buyers (QIBs): Entities like mutual funds, banks, and insurance companies, who invest large sums

Non-Institutional Investors (NIIs): High-net-worth individuals or entities investing above the retail threshold

Investors must have a Demat and trading account to apply, and in some cases, certain financial or residency qualifications may apply depending on local regulations.

SME (Small and Medium Enterprise) IPOs generally carry higher risk but may provide significant growth potential. Investors should research the company’s stability, financials, and sector risks, as SME stocks can be more volatile compared to large-cap companies.

View More

Disclaimer

This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.

Invalid Mobile Number

Invalid Full Name

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Home
Home
ONDC_Shopping
Shopping
Loan
Personal Loan
My Accounts
My Accounts
Explore
Explore